Skip to main content
Loading Loading
  



 
Sign In

  • SNMMI.ORG
  • Home
  • Education
  • Resources
  • Centers of Excellence
  • 2022 Fall ConferenceToggle
      • 2022 Therapeutics Conference
      • Register
      • Agenda
      • Housing/National Harbor
      • Exhibiting Companies
      • Exhibits and Sponsorships
  • About SNMMIToggle
      • Our Mission
      • About Nuclear Medicine and Molecular Imaging
      • Career Center
      • Grants and Awards
      • Support SNMMI

Education

Site Preparation for Establishing 177Lu-Radioligand Therapy Programs



There's a New PET Drug in Town: Manufacturing and Approval Consideration
for Your Institution



Theranostics: Regulatory Considerations for Product Development


SNMMI/NCI Third Targeted Radionuclide Therapy Conference 2019

Guidance Documents

Charging for Investigational Drugs Under an IND - Questions and Answers
Guidance for Industry
- June 2016




Expanded Access to Investigational Drugs for Treatment Use - Questions and Answers
Guidance for Industry
- June 2016

Therapy Implementation Checklist

  • Radiopharmaceutical Therapy Toolkit Checklist (PDF)
  • Radiopharmaceutical Therapy Toolkit Checklist (MS Word)

Tools for Technologists

These focused tools give nuclear medicine technologists direct access to learning modules, newsletter articles, and publications related to radiophamarceutical therapies.

Learn More   

Publications

  • Guidance on 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy from the Experience of a Single Nuclear Medicine Division
  • For more articles on nuclear medicine therapy from SNMMI journals, click here.

Connect with us




 

ADVERTISING  • LIST SALES • MEDIA • CONTACT • SITE MAP • LEGAL/DISCLAIMER COI • REPORT A PROBLEM
1850 Samuel Morse Drive  Reston, Virginia 20190  P: 703.708.9000  F: 703.708.9015
Download Acrobat Reader

Copyright © Society of Nuclear Medicine and Molecular Imaging.

{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##